Cargando…

In Vivo Evaluation of Fibroblast Growth Factor Receptor Inhibition in Mouse Xenograft Models of Gastrointestinal Stromal Tumor

Advanced gastrointestinal stromal tumors (GIST) are typically treated with tyrosine kinase inhibitors, and imatinib is the most commonly used standard of care in first line treatments. The use of this and other tyrosine kinase inhibitors is associated with objective tumor responses and prolongation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schöffski, Patrick, Gebreyohannes, Yemarshet, Van Looy, Thomas, Manley, Paul, Growney, Joseph D., Squires, Matthew, Wozniak, Agnieszka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138864/ https://www.ncbi.nlm.nih.gov/pubmed/35625872 http://dx.doi.org/10.3390/biomedicines10051135

Ejemplares similares

Characterization and assessment of the sensitivity and resistance of a newly established human gastrointestinal stromal tumour xenograft model to treatment with tyrosine kinase inhibitors
por: Van Looy, Thomas, et al.
Publicado: (2014)

Plocabulin, a novel tubulin inhibitor, has potent antitumor activity in patient-derived xenograft models of gastrointestinal stromal tumors
por: Wang, Yannick, et al.
Publicado: (2020)

Therapeutic Efficacy Assessment of CK6, a Monoclonal KIT Antibody, in a Panel of Gastrointestinal Stromal Tumor Xenograft Models()()
por: Van Looy, Thomas, et al.
Publicado: (2015)

Assessment of the platelet-derived growth factor receptor alpha antibody olaratumab in a panel of patient-derived soft tissue sarcoma xenografts
por: Cornillie, Jasmien, et al.
Publicado: (2019)

Metabolomic and transcriptomic response to imatinib treatment of gastrointestinal stromal tumour in xenograft-bearing mice
por: Macioszek, Szymon, et al.
Publicado: (2023)

Differential antitumor activity of compounds targeting the ubiquitin-proteasome machinery in gastrointestinal stromal tumor (GIST) cells
por: Rausch, Jessica L., et al.
Publicado: (2020)

Pazopanib, a Receptor Tyrosine Kinase Inhibitor, Suppresses Tumor Growth through Angiogenesis in Dedifferentiated Liposarcoma Xenograft Models()()()
por: Li, Haifu, et al.
Publicado: (2014)

A Robust Method for Sample Preparation of Gastrointestinal Stromal Tumour for LC/MS Untargeted Metabolomics
por: Macioszek, Szymon, et al.
Publicado: (2021)

Ferroptosis Induction and YAP Inhibition as New Therapeutic Targets in Gastrointestinal Stromal Tumors (GISTs)
por: Delvaux, Marine, et al.
Publicado: (2022)

The in vivo malignant transformation of mouse fibroblasts in the presence of human tumour xenografts.
por: Sparrow, S., et al.
Publicado: (1986)

Clinical implications of mutational analysis in gastrointestinal stromal tumours
por: Hoeben, A, et al.
Publicado: (2008)

Plocabulin, a Novel Tubulin Inhibitor, Has Potent Antitumour Activity in Patient-Derived Xenograft Models of Soft Tissue Sarcoma
por: Wang, Yannick, et al.
Publicado: (2022)

Enapotamab Vedotin, an AXL-Specific Antibody-Drug Conjugate, Demonstrates Antitumor Efficacy in Patient-Derived Xenograft Models of Soft Tissue Sarcoma
por: Van Renterghem, Britt, et al.
Publicado: (2022)

Targeting INHBA in Ovarian Cancer Cells Suppresses Cancer Xenograft Growth by Attenuating Stromal Fibroblast Activation
por: Li, Xiaoting, et al.
Publicado: (2019)

Generation of orthotopic patient-derived xenografts from gastrointestinal stromal tumor
por: Sicklick, Jason K, et al.
Publicado: (2014)

Cancer-associated fibroblast secretion of PDGFC promotes gastrointestinal stromal tumor growth and metastasis
por: Yoon, Hyunho, et al.
Publicado: (2021)

In Vivo Detection of Circulating Cancer-Associated Fibroblasts in Breast Tumor Mouse Xenograft: Impact of Tumor Stroma and Chemotherapy
por: Lu, Tao, et al.
Publicado: (2023)

Stromal impact on tumor growth and lymphangiogenesis in human carcinoma xenografts
por: Hadler-Olsen, Elin, et al.
Publicado: (2010)

Mouse Stromal Cells Confound Proteomic Characterization and Quantification of Xenograft Models
por: Shi, Zhaomei, et al.
Publicado: (2023)

Conditional ablation of heparan sulfate expression in stromal fibroblasts promotes tumor growth in vivo
por: Niwa, Ayumi, et al.
Publicado: (2023)

Inhibition of Stromal PlGF Suppresses the Growth of Prostate Cancer Xenografts
por: Zins, Karin, et al.
Publicado: (2013)

Optimal Avapritinib Treatment Strategies for Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumors
por: Joseph, Cissimol P., et al.
Publicado: (2021)

Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts
por: Pacioni, Simone, et al.
Publicado: (2017)

Monitoring the Effect of Targeted Therapies in a Gastrointestinal Stromal Tumor Xenograft Using a Clinical PET/CT
por: Revheim, Mona-Elisabeth, et al.
Publicado: (2010)

Establishment and characterization of patient-derived xenograft models of gastrointestinal stromal tumor resistant to standard tyrosine kinase inhibitors
por: Na, Young-Soon, et al.
Publicado: (2017)

Enhanced Antitumor Efficacy of PhAc-ALGP-Dox, an Enzyme-Activated Doxorubicin Prodrug, in a Panel of THOP1-Expressing Patient-Derived Xenografts of Soft Tissue Sarcoma
por: Van Renterghem, Britt, et al.
Publicado: (2022)

In vivo photoacoustic tomography of EGFR overexpressed in hepatocellular carcinoma mouse xenograft
por: Zhou, Quan, et al.
Publicado: (2016)

Methaneseleninic acid and γ-Tocopherol combination inhibits prostate tumor growth in Vivo in a xenograft mouse model
por: Singh, Chandra K., et al.
Publicado: (2014)

Establishment of patient-derived xenografts from patients with gastrointestinal stromal tumors: analysis of clinicopathological characteristics related to engraftment success
por: Na, Young-Soon, et al.
Publicado: (2020)

Prostaglandin production in mouse mammary tumour cells confers invasive growth potential by inducing hepatocyte growth factor in stromal fibroblasts
por: Matsumoto-Taniura, N, et al.
Publicado: (1999)

TGF-β1-mediated transition of resident fibroblasts to cancer-associated fibroblasts promotes cancer metastasis in gastrointestinal stromal tumor
por: Yoon, Hyunho, et al.
Publicado: (2021)

Molecular Comparison of Imatinib-Naïve and Resistant Gastrointestinal Stromal Tumors: Differentially Expressed microRNAs and mRNAs
por: Amirnasr, Azadeh, et al.
Publicado: (2019)

Role of Fibroblast Growth Factor Receptor 2 (FGFR2) in Corneal Stromal Thinning
por: Joseph, Roy, et al.
Publicado: (2023)

Senescent peritoneal mesothelium induces a pro-angiogenic phenotype in ovarian cancer cells in vitro and in a mouse xenograft model in vivo
por: Mikuła-Pietrasik, Justyna, et al.
Publicado: (2015)

New mouse xenograft model modulated by tumor-associated fibroblasts for human multi-drug resistance in cancer
por: MA, YAN, et al.
Publicado: (2015)

A Giant Gastrointestinal Stromal Tumor of the Stomach with Extramural Growth
por: Miyazaki, Ryosuke, et al.
Publicado: (2016)

Gastrointestinal stromal tumor
por: Stamatakos, Michael, et al.
Publicado: (2009)

Gastrointestinal stromal tumors
por: Beham, Alexander W., et al.
Publicado: (2011)

Calpain inhibitor calpeptin suppresses pancreatic cancer by disrupting cancer–stromal interactions in a mouse xenograft model
por: Yoshida, Masaki, et al.
Publicado: (2016)

High-risk gastrointestinal stromal tumour (GIST) and synovial sarcoma display similar angiogenic profiles: a nude mice xenograft study
por: Giner, Francisco, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ifg6b8g0j8jh6bp84mc26lvudf